By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Diagnostic solutions803.08M38.42%
Sample technologies661.27M31.64%
Polymerase Chain Reaction (PCR) / Nucleic acid amplification308.99M14.78%
Genomics / Next-Generation Sequencing (NGS)241.78M11.57%
Other74.89M3.58%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States998.45M47.77%
Europe, Middle East and Africa689.06M32.97%
Asia Pacific, Japan and Rest of World290.73M13.91%
Other Americas88.07M4.21%
Netherlands23.7M1.13%